Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

BIOPROBE FLUOR GENTAMICIN IN SERUM OR PLASMA

K-Number: K852158 · 1985-06-25

Decision Date1985-06-25
Product CodeLCQ
Advisory CommitteeTX
DecisionSubstantially Equivalent

Device Summary

BIOPROBE FLUOR GENTAMICIN IN SERUM OR PLASMA is the device name listed in this FDA 510(k) record. The listed applicant is Bioprobe Intl., Inc.. It received FDA 510(k) clearance on 1985-06-25 under 510(k) number K852158. The device is classified under product code LCQ. It was reviewed by the TX advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the BIOPROBE FLUOR GENTAMICIN IN SERUM OR PLASMA?

BIOPROBE FLUOR GENTAMICIN IN SERUM OR PLASMA is a medical device that received FDA 510(k) clearance on 1985-06-25. The listed applicant is Bioprobe Intl., Inc.. The 510(k) number is K852158.

When did BIOPROBE FLUOR GENTAMICIN IN SERUM OR PLASMA receive FDA 510(k) clearance?

BIOPROBE FLUOR GENTAMICIN IN SERUM OR PLASMA received FDA 510(k) clearance on 1985-06-25, under 510(k) number K852158.

Who is the listed applicant for BIOPROBE FLUOR GENTAMICIN IN SERUM OR PLASMA?

The FDA 510(k) record lists Bioprobe Intl., Inc. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for BIOPROBE FLUOR GENTAMICIN IN SERUM OR PLASMA?

The FDA product code for BIOPROBE FLUOR GENTAMICIN IN SERUM OR PLASMA is LCQ.

Related Clinical Trials

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

Related Devices (Code: LCQ)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.

↑